Delivering Guidelines for COPD and Pharma Partnership

1
Delivering Guidelines for COPDandPharma
Partnership

• Dr Ninian Hewitt
• Clinical Lead for Lothian Respiratory (COPD) MCN

2
Lothian COPD Guidelines

• Why?
• Patients needed better care and healthcare
  professionals needed concise and up-to-date
  information
• Outcome Patients with COPD will receive the
  best possible care

3
Lothian COPD Guidelines

• Who?
• Patients and carers were involved from the
  beginning. They gave their opinions and advice
  about
• The treatment they would like
• Issues they felt needed to be addressed
• Terminology discrepancies
• We also consulted a wide range of healthcare
  professionals including consultants, pharmacists,
  physiotherapists, physiologists, specialist
  nurses, GPs, stop smoking facilitators and many
  more

4
Lothian COPD Guidelines

• What?
• Diagnosis
• Risk factors
• Chest x-ray
• A1 antitrypsin deficiency
• Co-morbidities
• Treatment
• Delivery systems
• Pulmonary rehabilitation
• Exacerbations
• Referral to consultant
• Discharge and follow-up

• Palliative care
• Travelling with COPD
• Help agencies for patients and carers
• Patient information
• Contact information
• Primary care exacerbation protocol
• Pulmonary rehabilitation referral form
• COPD self-management plan

5
Lothian COPD Guidelines

• Lothian wide
• Includes an FAQ section
• Based on GOLD definitions
• Equality and diversity rapid impact assessment
  performed

6
Lothian COPD Guidelines

• How?
• Meetings were held in each CHP to introduce the
  guidelines along with educational sessions on
  spirometry and treatment. These were attended by
  almost 200 healthcare professionals
• Secondary care meetings will be held in each of
  the three main hospitals to discuss the
  guidelines
• An audit will be performed in 2010

7
Partnership with ABPI Scotland

• Guided by the Scottish Executive document A
  Common Understanding Guidance on Joint Working
  Between NHS Scotland and the Pharmaceutical
  Industry
• Participating under the umbrella of ABPI
  Scotland AstraZeneca, Boehringer Ingelheim,
  Chiesi, GlaxoSmithKline, and Pfizer

8
Partnership with ABPI Scotland

• Monthly meetings held between ABPI companies and
  MCN management
• ABPI companies offer support and resources but do
  not make decisions for the MCN
• ABPI companies have no input in treatment
  recommendations
• They have been extremely helpful with event
  organising, social marketing and project managing

9
Other achievements
10
Lothian Respiratory (COPD) MCN

• Thank you